drugset / Trial / NCT01556698

Study of NVN1000 Topical Gel and Topical Gel Vehicle in the Treatment of Moderate to Severe Acne Vulgaris

NCT01556698 ↗

Phase 1/2 Completed 70 enrolled Novan, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to compare the tolerability, safety and efficacy of NVN1000 Topical Gel and Topical Gel Vehicle in the treatment of subjects with moderate to severe acne vulgaris.

Timeline

Start
2011-07
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject BERDAZIMER SODIUM Small molecule 0.3 % Topical

Indications